305 related articles for article (PubMed ID: 26883759)
1. Small-molecule inhibitors of FGFR, integrins and FAK selectively decrease L1CAM-stimulated glioblastoma cell motility and proliferation.
Anderson HJ; Galileo DS
Cell Oncol (Dordr); 2016 Jun; 39(3):229-42. PubMed ID: 26883759
[TBL] [Abstract][Full Text] [Related]
2. Exosomal L1CAM Stimulates Glioblastoma Cell Motility, Proliferation, and Invasiveness.
Pace KR; Dutt R; Galileo DS
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426278
[TBL] [Abstract][Full Text] [Related]
3. L1CAM stimulates glioma cell motility and proliferation through the fibroblast growth factor receptor.
Mohanan V; Temburni MK; Kappes JC; Galileo DS
Clin Exp Metastasis; 2013 Apr; 30(4):507-20. PubMed ID: 23212305
[TBL] [Abstract][Full Text] [Related]
4. L1 stimulation of human glioma cell motility correlates with FAK activation.
Yang M; Li Y; Chilukuri K; Brady OA; Boulos MI; Kappes JC; Galileo DS
J Neurooncol; 2011 Oct; 105(1):27-44. PubMed ID: 21373966
[TBL] [Abstract][Full Text] [Related]
5. A small-molecule RGD-integrin antagonist inhibits cell adhesion, cell migration and induces anoikis in glioblastoma cells.
Russo MA; Paolillo M; Sanchez-Hernandez Y; Curti D; Ciusani E; Serra M; Colombo L; Schinelli S
Int J Oncol; 2013 Jan; 42(1):83-92. PubMed ID: 23174862
[TBL] [Abstract][Full Text] [Related]
6. A simple and accurate rule-based modeling framework for simulation of autocrine/paracrine stimulation of glioblastoma cell motility and proliferation by L1CAM in 2-D culture.
Caccavale J; Fiumara D; Stapf M; Sweitzer L; Anderson HJ; Gorky J; Dhurjati P; Galileo DS
BMC Syst Biol; 2017 Dec; 11(1):124. PubMed ID: 29228953
[TBL] [Abstract][Full Text] [Related]
7. EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation.
Kiefel H; Bondong S; Pfeifer M; Schirmer U; Erbe-Hoffmann N; Schäfer H; Sebens S; Altevogt P
Carcinogenesis; 2012 Oct; 33(10):1919-29. PubMed ID: 22764136
[TBL] [Abstract][Full Text] [Related]
8. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells.
Natarajan M; Stewart JE; Golemis EA; Pugacheva EN; Alexandropoulos K; Cox BD; Wang W; Grammer JR; Gladson CL
Oncogene; 2006 Mar; 25(12):1721-32. PubMed ID: 16288224
[TBL] [Abstract][Full Text] [Related]
9. A selective cyclic integrin antagonist blocks the integrin receptors alphavbeta3 and alphavbeta5 and inhibits retinal pigment epithelium cell attachment, migration and invasion.
Hoffmann S; He S; Jin M; Ehren M; Wiedemann P; Ryan SJ; Hinton DR
BMC Ophthalmol; 2005 Jun; 5():16. PubMed ID: 15987521
[TBL] [Abstract][Full Text] [Related]
10. Cilengitide targets pediatric glioma and neuroblastoma cells through cell detachment and anoikis induction.
Leblond P; Dewitte A; Le Tinier F; Bal-Mahieu C; Baroncini M; Sarrazin T; Lartigau E; Lansiaux A; Meignan S
Anticancer Drugs; 2013 Sep; 24(8):818-25. PubMed ID: 23728220
[TBL] [Abstract][Full Text] [Related]
11. Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependency.
Mikkelsen T; Brodie C; Finniss S; Berens ME; Rennert JL; Nelson K; Lemke N; Brown SL; Hahn D; Neuteboom B; Goodman SL
Int J Cancer; 2009 Jun; 124(11):2719-27. PubMed ID: 19199360
[TBL] [Abstract][Full Text] [Related]
12. PI3K p110β isoform synergizes with JNK in the regulation of glioblastoma cell proliferation and migration through Akt and FAK inhibition.
Zhao HF; Wang J; Jiang HR; Chen ZP; To SS
J Exp Clin Cancer Res; 2016 May; 35():78. PubMed ID: 27176481
[TBL] [Abstract][Full Text] [Related]
13. Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway.
Oliveira-Ferrer L; Hauschild J; Fiedler W; Bokemeyer C; Nippgen J; Celik I; Schuch G
J Exp Clin Cancer Res; 2008 Dec; 27(1):86. PubMed ID: 19114005
[TBL] [Abstract][Full Text] [Related]
14. In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase.
Panek RL; Lu GH; Dahring TK; Batley BL; Connolly C; Hamby JM; Brown KJ
J Pharmacol Exp Ther; 1998 Jul; 286(1):569-77. PubMed ID: 9655904
[TBL] [Abstract][Full Text] [Related]
15. Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma.
Skuli N; Monferran S; Delmas C; Favre G; Bonnet J; Toulas C; Cohen-Jonathan Moyal E
Cancer Res; 2009 Apr; 69(8):3308-16. PubMed ID: 19351861
[TBL] [Abstract][Full Text] [Related]
16. L1 cell adhesion molecule induces melanoma cell motility by activation of mitogen-activated protein kinase pathways.
Yi YS; Baek KS; Cho JY
Pharmazie; 2014 Jun; 69(6):461-7. PubMed ID: 24974583
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and Biological Evaluation of Covalent Inhibitors of Focal Adhesion Kinase (FAK) against Human Malignant Glioblastoma.
Li B; Li Y; Tomkiewicz-Raulet C; Dao P; Lietha D; Yen-Pon E; Du Z; Coumoul X; Garbay C; Etheve-Quelquejeu M; Chen H
J Med Chem; 2020 Nov; 63(21):12707-12724. PubMed ID: 33119295
[TBL] [Abstract][Full Text] [Related]
18. Specific inhibitor of FGF receptor signaling: FGF-2-mediated effects on proliferation, differentiation, and MAPK activation are inhibited by PD173074 in oligodendrocyte-lineage cells.
Bansal R; Magge S; Winkler S
J Neurosci Res; 2003 Nov; 74(4):486-93. PubMed ID: 14598292
[TBL] [Abstract][Full Text] [Related]
19. The adhesion molecule L1 (CD171) promotes melanoma progression.
Meier F; Busch S; Gast D; Göppert A; Altevogt P; Maczey E; Riedle S; Garbe C; Schittek B
Int J Cancer; 2006 Aug; 119(3):549-55. PubMed ID: 16506207
[TBL] [Abstract][Full Text] [Related]
20. Differential role of proline-rich tyrosine kinase 2 and focal adhesion kinase in determining glioblastoma migration and proliferation.
Lipinski CA; Tran NL; Bay C; Kloss J; McDonough WS; Beaudry C; Berens ME; Loftus JC
Mol Cancer Res; 2003 Mar; 1(5):323-32. PubMed ID: 12651906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
